Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF)

International Journal of Cardiology

Volumn 220, Issue , 2016, Pages 750-758

  Makubi, Abel ^a,b,c   Hage, Camilla ^a   Sartipy, Ulrik ^a   Lwakatare, Johnson ^b,c   Janabi, Mohammed ^b,c   Kisenge, Peter ^c   Dahlström, Ulf ^d   Rydén, Lars ^a,e   Makani, Julie ^b,f,g   Lund, Lars H ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c Jakaya Kikwete Cardiac Institute   (Tanzania)

^d LINKÖPING UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g Muhimbili Wellcome Programme   (Tanzania)

Author keywords

Heart failure; Mortality; Sub Saharan Africa; Sweden; Tanzania

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; NITRIC ACID DERIVATIVE; SPIRONOLACTONE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE REGISTRY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; SWEDEN; TANZANIA; VERY ELDERLY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; MIDDLE AGED; REGISTER;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; SWEDEN; TANZANIA;

EID: 84977142620     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.06.239     Document Type: Article

References (29)

1. [1] Liu, L., Eisen, H.J., Epidemiology of heart failure and scope of the problem. Cardiol. Clin. 32 (2014), 1–8.
2. [2] McMurray, J.J., Stewart, S., Heart failure: epidemiology, aetiology, and prognosis of heart failure. Heart 83 (2000), 596–602.
3. [3] Ntusi, N.B.a., Mayosi, B.M., Epidemiology of heart failure in sub-Saharan Africa. Expert. Rev. Cardiovasc. Ther. 7 (2009), 169–180.
4. [4] Mayosi, B.M., Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 93 (2007), 1176–1183.
5. [5] Makubi, A., Hage, C., Lwakatare, J., Kisenge, P., Makani, J., Rydén, L., Lund, L.H., Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study. Heart, 2014, 1–7.
6. [6] Adams, K.F., Fonarow, G.C., Emerman, C.L., LeJemtel, T.H., Costanzo, M.R., Abraham, W.T., Berkowitz, R.L., Galvao, M., Horton, D.P., Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 149 (2005), 209–216.
7. [7] Mentz, R.J., Fiuzat, M., Wojdyla, D.M., Chiswell, K., Gheorghiade, M., Fonarow, G.C., O'Connor, C.M., Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur. J. Heart Fail. 14 (2012), 395–403.
8. [8] Zarrinkoub, R., Wettermark, B., Wändell, P., Mejhert, M., Szulkin, R., Ljunggren, G., Kahan, T., The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur. J. Heart Fail. 15 (2013), 995–1002.
9. [9] Nieminen, M.S., Brutsaert, D., Dickstein, K., Drexler, H., Follath, F., Harjola, V.-P., Hochadel, M., Komajda, M., Lassus, J., Lopez-Sendon, J.L., Ponikowski, P., Tavazzi, L., EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur. Heart J. 27 (2006), 2725–2736.
10. [10] Gerber, Y., Weston, S.a., Redfield, M.M., Chamberlain, A.M., Manemann, S.M., Jiang, R., Killian, J.M., Roger, V.L., A contemporary appraisal of the heart failure epidemic in Olmsted county, Minnesota, 2000 to 2010. JAMA Intern. Med. 175 (2015), 996–1004.
11. [11] Sliwa, K., Mayosi, B.M., Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart 99 (2013), 1317–1322.
12. [12] Damasceno, A., Mayosi, B.M., Sani, M., Ogah, O.S., Mondo, C., Ojji, D., Dzudie, A., Kouam, C.K., Suliman, A., Schrueder, N., Yonga, G., Ba, S.A., Maru, F., Alemayehu, B., Edwards, C., Davison, B.A., Cotter, G., Sliwa, K., The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch. Intern. Med. 172 (2012), 1386–1394.
13. [13] Sliwa, K., Mayosi, B.M., Recent Advances in the Epidemiology, Pathogenesis and Prognosis of Acute Heart Failure and Cardiomyopathy in Africa. 2013, 1–6 (doi:10.1136/heartjnl-2013-303592).
14. [14] Mcmurray, J.J.V., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y.H., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.a., Ronnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.a., Zannad, F., Zeiher, A., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, J., Kolh, P., Mcdonagh, T., Moulin, C., Reiner, Ž., Sechtem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Bonet, L.A., Avraamides, P., Lamin, H.a.B., Brignole, M., Coca, A., Cowburn, P., Dargie, H., Elliott, P., Flachskampf, F.A., Guida, G.F., Hardman, S., Iung, B., Merkely, B., Mueller, C., Nanas, J.N., Nielsen, O.W., Orn, S., Parissis, J.T., Ponikowski, P., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. J. Heart Fail. 14:2012 (2012), 803–869.
15. [15] Jonsson, A., Edner, M., Alehagen, U., Dahlström, U., Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur. J. Heart Fail. 12 (2010), 25–31.
16. [16] Lund, L.H., Benson, L., Dahlström, U., Edner, M., Friberg, L., Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction. JAMA, 312, 2014, 2008.
17. [17] Thorvaldsen, T., Benson, L., Dahlström, U., Edner, M., Lund, L.H., Use of evidence-based therapy and survival in heart failure in Sweden 2003–2012. Eur. J. Heart Fail., 2016.
18. [18] Damasceno, A., Mayosi, B.M., Sani, M., Ogah, O.S., Mondo, C., Ojji, D., Dzudie, A., Kouam, C.K., Suliman, A., Schrueder, N., Yonga, G., Ba, S.A., Maru, F., Alemayehu, B., Edwards, C., Davison, B.a., Cotter, G., Sliwa, K., The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch. Intern. Med. 172 (2012), 1386–1394.
19. [19] Sliwa, K., Davison, B.a., Mayosi, B.M., Damasceno, A., Sani, M., Ogah, O.S., Mondo, C., Ojji, D., Dzudie, A., Kouam Kouam, C., Suliman, A., Schrueder, N., Yonga, G., Ba, S.A., Maru, F., Alemayehu, B., Edwards, C., Cotter, G., Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry. Eur. Heart J. 34 (2013), 3151–3159.
20. [20] Stewart, S., Wilkinson, D., Hansen, C., Vaghela, V., Mvungi, R., McMurray, J., Sliwa, K., Predominance of heart failure in the Heart of Soweto Study Cohort: emerging challenges for urban African communities. Circulation 118 (2008), 2360–2367.
21. [21] Azad, N., Kathiravelu, A., Minoosepeher, S., Hebert, P., Fergusson, D., Gender differences in the etiology of heart failure : A systematic review. 2011, 15–23.
22. [22] Ogah, O.S., Davison, B.A., Sliwa, K., Mayosi, B.M., Damasceno, A., Sani, M.U., Mondo, C., Dzudie, A., Ojji, D.B., Kouam, C., Suliman, A., Schrueder, N., Yonga, G., Ba, S.A., Maru, F., Alemayehu, B., Edwards, C., Cotter, G., Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa : results of the THESUS-HF study. Clin. Res. Cardiol., 481–490, 2015.
23. [23] Ofili, E.O., Mayberry, R., Alema-mensah, E., Saleem, S., Hamirani, K., Jones, C., Salih, S., Lankford, B., Oduwole, A., Igho-pemu, P., Gender Differences and Practice Implications of Risk Factors for Frequent Hospitalization for Heart Failure in an African-American Patients, 9149. 1999.
24. [24] Echouffo-Tcheugui, J.B., Kengne, A.P., Erqou, S., Cooper, R.S., High blood pressure in sub-Saharan Africa: the urgent imperative for prevention and control. J. Clin. Hypertens., 2015 (n/a–n/a).
25. [25] Makubi, A., Hage, C., Lwakatare, J., Mmbando, B., Kisenge, P., Lund, L.H., Rydén, L., Makani, J., Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure. Heart 101 (2015), 592–599 (doi:).
26. [26] Lee, D.S., Gona, P., Vasan, R.S., Larson, M.G., Benjamin, E.J., Wang, T.J., Tu, J.V., Levy, D., Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: Insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 119 (2009), 3070–3077.
27. [27] Henkel, D.M., Redfield, M.M., Weston, S.a., Gerber, Y., Roger, V.L., Death in heart failure: a community perspective. Circ. Heart Fail. 1 (2008), 91–97.
28. [28] Yusuf, S., Pfeffer, M.A., Swedberg, K., Granger, C.B., Held, P., McMurray, J.J.V., Michelson, E.L., Olofsson, B., Ostergren, J., Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003), 777–781 (London, England).
29. [29] Davis, B.R., Kostis, J.B., Simpson, L.M., Black, H.R., Cushman, W.C., Einhorn, P.T., Farber, M.a., Ford, C.E., Levy, D., Massie, B.M., Nawaz, S., Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation 118 (2008), 2259–2267.